Epithelial to mesenchymal transition (EMT) is a fundamental process, paradigmatic of the concept of cell plasticity, that leads epithelial cells to lose their polarization and specialized junctional structures, to undergo cytoskeleton reorganization, and to acquire morphological and functional features of mesenchymal-like cells. Although EMT has been originally described in embryonic development, where cell migration and tissue remodeling have a primary role in regulating morphogenesis in multicellular organisms, recent literature has provided evidence suggesting that the EMT process is a more general biological process that is also involved in several pathophysiological conditions, including cancer progression and organ fibrosis. This review offers first a comprehensive introduction to describe major relevant features of EMT, followed by sections dedicated on those signaling mechanisms that are known to regulate or affect the process, including the recently proposed role for oxidative stress and reactive oxygen species (ROS). Current literature data involving EMT in both physiological conditions (i.e., embryogenesis) and major human diseases are then critically analyzed, with a special final focus on the emerging role of hypoxia as a relevant independent condition able to trigger EMT. Antioxid. Redox Signal. 12, 1383–1430.
AbeR, DonnellySC, PengT, BucalaR, MetzCN. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol, 166:7556–7562. 2001.
2.
AcloqueH, AdamsMS, FishwickK, Bronner–FraserM, NietoMA. Epithelial–mesenchymal transitions: The importance of changing cell state in development and disease. J Clin Invest, 119:1438–1449. 2009.
ArnouxV, ComeC, KusewittD, HudsonL, SavagnerP. Cutaneous wound re-riepithellalization: A partial and reversible EMT. Rise and Fall of Epithelial Phenotype: Concepts of Epithelial–Mesenchymal Transition. SavagnerP. Berlin: Springer, 2005; 11–134.
5.
ArnouxV, NassourM, L'Helgoualc'hA, HipskindRA, SavagnerP. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell, 19:4738–4749. 2008.
6.
AvizienyteE, FrameMC. Src and FAK signaling control adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol, 17:542–547. 2005.
7.
BabiorBM. NADPH oxidase: An update. Blood, 93:1464–1476. 1999.
8.
BachelderRE, YoonS–O, FranciC, Garcia de HerrerosA, MercurioA. Glycogen synthase kinase 3 is an endogenous inhibitor of Snail transcription: implications for the epithelial–mesenchymal transition. J Cell Biol, 168:29–33. 2005.
9.
BagnatoA, RosanòL. Epithelial–mesenchymal transition in ovarian cancer progression: A crucial role for the endothelin axis. Cells Tissues Organs, 185:85–94. 2007.
10.
BaileyJM, SinghPK, HollingsworthMA. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem, 102:829–839. 2007.
11.
BakinAV, TomlinsonAK, BhowmickNA, MosesHL, ArteagaCL. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem, 275:36803–36810. 2000.
12.
BarberàMJ, PuigI, DomínguezD, Julien–GrilleS, Guaita–EsteruelasS, PeiróS, BaulidaJ, FrancíC, DedharS, LarueL, García de HerrerosA. Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene, 23:7345–7354. 2004.
BatlleE, SanchoE, FranciC, DominguezD, MonfarM, BaulidaJ, Garcia De HerrerosA. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol, 2:84–89. 2000.
15.
BaumB, SettlemanJ, QuinlanMP. Transitions between epithelial and mesenchymal states in development and disease. Sem Cell Dev Biol, 19:294–308. 2008.
16.
BeckerKF, RosivatzE, BlechschmidtK, KremmerE, SarbiaM, HöflerH. Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs, 185:204–212. 2007.
17.
BenitahSA, ValerónPF, RuiH, LacalJC. STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA. Mol Biol Cell, 14:40–53. 2003.
18.
BerndtC, LilligCH, HolmgrenA. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems: Implications for diseases in the cardiovascular system. Am J Physiol Heart Circ Physiol, 292:1227–1236. 2007.
19.
BhowmickNA, GhiassiM, BakinA, AakreM, LundquistCA, EngelME, ArteagaCL, MosesHL. Transforming factor-β1 mediates epithelial to mesenchymal trans-differentiation through a RhoA-dependent mechanism. Mol Biol Cell, 12:27–36. 2001.
20.
BirchmeierC, BirchmeierW, Brand–SaberiB. Epithelial–mesenchymal transitions in cancer progression. Acta Anat (Basel), 156:217–226. 1996.
21.
BlancoMJ, Moreno–BuenoG, SarrioD, LocascioA, CanoA, PalaciosJ, NietoMA. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene, 21:3241–3246. 2002.
22.
Bloushtain–QimronN, YaoJ, SnyderEL, ShipitsinM, CampbellLL, ManiSA, HuM, ChenH, UstyanskyV, AntosiewiczJE, ArganiP, HalushkaMK, ThomsonJA, PharoahP, PorgadorA, SukumarS, ParsonsR, RichardsonAL, StampferMR, GelmanRS, NikolskayaT, NikolskyY, PolyakK. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA, 105:14076–14081. 2008.
23.
BonizziG, KarinM. The two NF-kappaB activation pathways and their role in innate and adaptative immunity. Trends Immunol, 25:280–288. 2004.
24.
BoyerB, DufourS, ThieryJP. E-cadherin expression during the acidic FGF-induced dispersion of a rat bladder carcinoma cell line. Exp Cell Res, 201:347–357. 1992.
25.
BoyerB, RocheS, DenoyelleM, ThieryJP. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J, 16:5904–5913. 1997.
26.
BoyerB, ThieryJP. Epithelium–mesenchyme interconversion as example of epithelial plasticity. APMIS, 101:257–268. 1993.
27.
BoyerB, VallésAM, EdmeN. Induction and regulation of epithelial–mesenchymal transitions. Biochem Pharmacol, 60:1091–1099. 2000.
28.
BrabletzS, SchmalhoferO, BrabletzT. Gastrointestinal stem cells in development and cancer. J Pathol, 217:307–317. 2009.
29.
BrabletzT, JungA, SpadernaS, HlubekF, KirchnerT. Migrating cancer stem cells. An integrated concept of malignant tumour progression. Nature Rev Cancer, 5:744–749. 2005.
ChiarugiP, CirriP. Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction. Trends Biochem Sci, 28:509–514. 2003.
40.
ChoHY, ReddySP, KleebergerSR. Nrf2 defends the lung from oxidative stress. Antioxid Redox Signal, 8:76–87. 2006.
41.
ChuaHL, Bhat–NakshatriP, ClareSE, MorimiyaA, BadveS, NakshatriH. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2. Oncogene, 26:711–724. 2007.
CômeC, MagninoF, BibeauF, De Santa BarbaraP, BeckerKF, TheilletC, SavagnerP. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res, 12:5395–5402. 2006.
ComportiM, SignoriniC, ArezziniB, VecchioD, MonacoB, GardiC. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med, 44:247–256. 2008.
46.
Conacci–SorrellM, SimchaI, Ben–YedidiaT, BlechmanJ, SavagnerP, Ben–Ze'evA. Autoregulation of E-cadherin expression by cadherin–cadherin interactions: The roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol, 163:847–957. 2003.
47.
CorvolH, FlameinF, EpaudR, ClementA, GuillotL. Lung alveolar epithelium and interstitial lung disease. Int J Biochem Cell Biol, 41:1643–1651. 2009.
48.
D'AutrèauxB, ToledanoMB. ROS as signaling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol., 8:813–824. 2007.
49.
DaviesM, RobinsonM, SmithE, HuntleyS, PrimeS, PatersonI. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signaling pathways. J Cell Biochem, 95:918–931. 2005.
50.
DaviesJA. Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat, 156:187–51.201. 1996.
51.
Den HertogJ, GroenA, Van der WijkT. Redox regulation of protein-tyrosine phosphatases. Arch Biochem Biophys, 434:11–15. 2005.
52.
DewhirstMW, CaoY, MoellerB. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer, 8:425–437. 2008.
DíazR, KimJW, HuiJJ, LiZ, SwainGP, FongKS, CsiszarK, RussoPA, RandEB, FurthEE, WellsRG. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol, 39:102–115. 2008.
55.
DingQ, XiaW, LiuJC, YangJY, LeeDF, XiaJ, BartholomeuszG, LiY, PanY, LiZ, BargouRC, QinJ, LaiCC, TsaiFJ, TsaiCH, HungMC. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell, 19:159–170. 2005.
56.
DjamaliA, ReeseS, YrachetaJ, OberleyT, HullettD, BeckerB. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant, 5:500–509. 2005.
57.
DjamaliA, VidyasagarA, AdullaM, HullettD, ReeseS. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant, 9:74–82. 2009.
58.
DonatoR. S100: A multigenic family of calcium modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol, 33:637–668. 2001.
59.
DongR, LuJG, WangQ, HeXL, ChuYK, MaQJ. Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. Biochem Biophys Res Commun, 356:318–321. 2007.
DumontN, WilsonMB, CrawfordYG, ReynoldsPA, SigaroudiniaM, TlstyTD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA, 105:14867–14872. 2008.
65.
EdmeN, DownwardJ, ThieryJP, BoyerB. Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci, 115:2591–2601. 2002.
66.
Esquela–KerscherA, SlackFJ. Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer, 6:259–269. 2006.
67.
EsterbauerH, SchaurRJ, ZollnerH. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med, 11:81–128. 1991.
68.
EvansJL, GoldfineID, MadduxBA, GrodskyGM. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev, 23:599–622. 2003.
69.
FarrellGC, LarterCZ. Nonalcoholic fatty liver diseases: From steatosis to cirrhosis. HepatologySuppl 1:S99–S112. 2006
70.
FaustoN. Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells. Hepatology, 39:1477–1487. 2004.
FitchettJE, HayED. Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse. Dev Biol, 131:455–474. 1989.
73.
FrameS, CohenP. GSK3 takes centre stage more than 20 years after its discovery. Biochem J, 359:1–16. 2001.
74.
FriedlP. Prespecification and plasticity: Shifting mechanisms of cell migration. Curr Opin Cell Biol, 16:14–23. 2004.
75.
FriedmanSL. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 88:125–172. 2008.
76.
FriedmanSL. Mechanisms of hepatic fibrogenesis. Gastroenterology, 134:1655–1669. 2008.
77.
FujitaY, KrauseG, ScheffnerM, ZechnerD, LeddyHE, BehrensJ, SommerT, BirchmeierW. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol, 4:222–231. 2002.
78.
FunatoY, MichiueT, AsashimaM, MikiH. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt-beta-catenin signaling through dishevelled. Nat Cell Biol, 8:501–508. 2006.
79.
GalliherAJ, SchiemannWP. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res, 8:R42. 2006.
80.
GebeshuberCA, ZatloukalK, MartinezJ. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep, 10:400–405. 2009.
GloireG, Legrand–PoelsS, PietteJ. NF-κB activation by reactive oxygen species: Fifteen years later. Biochem Pharmacol, 72:1493–1505. 2006.
83.
GordonKJ, KirkbrideKC, HowT, BlobeGC. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Carcinogenesis, 30:238–248. 2009.
84.
GortEH, GrootAJ, van der WallE, van DiestPJ, VooijsMA. Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med, 8:60–67. 2008.
85.
GotohY, CooperJA. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction. J Biol Chem, 273:17477–17482. 1998.
86.
GreenburgG, HayED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol, 95:333–339. 1982.
87.
GregoryPA, BertAG, PatersonEL, BarrySC, TsykinA, FarshidG, VadasMA, Khew–GoodallY, GoodallGJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol, 10:593–601. 2008.
88.
GuarinoM, RubinoB, BallabioG. The role of epithelial to mesenchymal transition in cancer pathology. Pathology, 39:305–318. 2007.
89.
GuarinoM. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol, 10:171–184. 1995.
90.
GuilfordP. E-cadherin down-regulation in cancer: Fuel on the fire?Mol Med Today, 5:172–177. 1999.
91.
HalliwellB, GutteridgeJMC. 3. Antioxidant defences: Endogenous and diet derived. Free Radicals in Biology and Medicine, 4th. Oxford, U.K.: Clarendon Press, 2006; 79–185.
92.
HalliwellB, WhitemanM. Measuring reactive species and oxidative damage in vivo and in cell culture: How should you do it and what do the results mean?Br J Pharmacol, 142:231–255. 2004.
93.
HarmanD. Aging: A theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
94.
HarmanD. The aging process. Proc Natl Acad Sci USA, 78:7124–7128. 1981.
95.
HarrisonD, GriendlingKK, LandmesserU, HornigB, DrexlerH. Role of oxidative stress in atherosclerosis. Am J Cardiol, 91:7A–11A. 2003.
96.
HayED. Organization and fine structure of epithelium and mesenchyme in the developing chick embryo. Epithelial-Mesenchymal Interactions; 18th Hahnemann Symposium. FleischmajerR, BillinghamRE. Baltimore, MD: Williams & Wilkins Co, 1968; 31–55.
97.
HayED. The mesenchymal cell: Its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn, 233:706–720. 2005.
98.
HigginsDF, KimuraK, BernhardtWM, ShrimankerN, AkaiY, HohensteinB, SaitoY, JohnsonRS, KretzlerM, CohenCD, EckardtKU, IwanoM, HaaseVH. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest, 117:3810–3820. 2007.
99.
HigginsDF, KimuraK, IwanoM, HaaseVH. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle, 7:1128–1132. 2008.
100.
HillRP, Marie–EgyptienneDT, HedleyDW. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol, 19:106–111. 2009.
101.
HirohashiS. Inactivation of the E-cadherin-mediated cell adhesion system in human cancer. Am J Pathol, 153:333–339. 1999.
102.
HouZ, PengH, AyyanathanK, YanKP, LangerEM, LongmoreGD, RauscherFJ3rd. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol, 28:3198–3207. 2008.
103.
HsuT, TrojanowskaM, WatsonDK. Ets proteins in biological control and cancer. J Cell Biochem, 91:896–903. 2004.
104.
HuberMA, KrautN, BeugH. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol, 17:1–11. 2005.
105.
HutvágnerG, McLachlanJ, PasquinelliAE, BálintE, TuschlT, ZamorePD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science, 293:834–838. 2001.
106.
IgnarroLJ, KadowitzPJ. The pharmacological and physiological role of cGMP in vascular smooth muscle relaxation. Ann Pharmacol Toxicol, 25:171–191. 1985.
107.
ImaiT, HoriuchiA, WangC, OkaK, OhiraS, NikaidoT, KonishiI. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol, 163:1437–1447. 2003.
108.
IredaleJP. Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organism. J Clin Invest, 117:539–548. 2007.
109.
IwanoM, PliethD, DanoffTM, XueC, OkadaH, NeilsonEG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest, 110:341–350. 2002.
110.
JainR, ShaulPW, BorokZ, WillisBC. Endothelin-1 induces alveolar epithelial -mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. Am J Respir Cell Mol Biol, 37:38–47. 2007.
111.
JungY, BrownKD, WitekRP, OmenettiA, YangL, VandongenM, MiltonRJ, HinesIN, RippeRA, SpahrL, Rubbia–BrandtL, DiehlAM. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology, 134:1532–1543. 2008.
112.
JungY, McCallSJ, LiYX, DiehlAM. Bile ductules and stromal cells express hedgehog ligands and/or hedgehog target genes in primary biliary cirrhosis. Hepatology, 45:1091–1096. 2007.
113.
KaimoriA, PotterJ, KaimoriJY, WangC, MezeyE, KoteishA. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem, 282:22089–22101. 2007.
114.
KalluriK, WeinbergRA. The basics of epithelia–mesenchymal transition. J Clin Invest, 119:1420–1428. 2009.
115.
KalluriR, NeilsonEG. Epithelial–mesenchymal transition and its implications for fibrosis. J Clin Invest, 112:1776–1784. 2003.
116.
KamataH, HondaS, MaedaS, ChangL, HirataH, KarinM. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120:649–661. 2005.
117.
KanetoH, KatakamiN, KawamoriD, MiyatsukaT, SakamotoK, MatsuokaTA, MatsuhisaM, YamasakiY. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal, 9:355–366. 2007.
118.
KeelyPJ. Rho GTPases as early markers of tumour progression. Lancet, 358:1744–1745. 2001.
119.
KimKK, KuglerMC, WoltersPJ, RobillardL, GalvezMG, BrumwellAN, SheppardD, ChapmanHA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA, 103:13180–13185. 2006.
KlymkowskyMW, SavagnerP. Epithelial–mesenchymal transition: A cancer researcher's conceptual friend and foe. Am J Pathol, 174:1588–1593. 2009.
127.
KoivistoL, JiangG, HäkkinenL, ChanB, LarjavaH. HaCaT keratinocyte migration is dependent on epidermal growth factor receptor signaling and glycogen synthase kinase-3alpha. Exp Cell Res, 312:2791–2805. 2006.
128.
KondoM, CubilloE, TobiumeK, ShirakiharaT, FukudaN, SuzukiH, ShimizuK, TakeharaK, CanoA, SaitohM, MiyazonoK. A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation. Cell Death Differ, 11:1092–1101. 2004.
129.
KongD, WangZ, SarkarSH, LiY, BanerjeeS, SaligananA, KimHR, CherML, SarkarFH. Platelet-derived growth factor-D overexpression contributes to epithelial–mesenchymal transition of PC3 prostate cancer cells. Stem Cells, 26:1425–1435. 2008.
130.
KongD, LiY, WangZ, BanerjeeS, AhmadA, KimHR, SarkarFH. miR-200 regulates PDGF-D-mediated epithelial–mesenchymal transition, adhesion, and invasion of prostate cancer cells. Stem Cells, 27:1712–1721. 2009.
131.
KongW, YangH, HeL, ZhaoJJ, CoppolaD, DaltonWS, ChengJQ. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol, 28:6773–6784. 2008.
132.
KorpalM, LeeES, HuG, KangY. The miR-200 family inhibits epithelial–mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem, 283:14910–14914. 2008.
133.
KusewittDF, ChoiC, NewkirkKM, LeroyP, LiY, ChavezMG, HudsonLG. Slug/Snai2 is a downstream mediator of epidermal growth factor receptor-stimulated re-epithelialization. J Invest Dermatol, 129:491–495. 2009.
134.
LabbéE, LetamendiaA, AttisanoL. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA, 97:8358–8363. 2000.
135.
LabbéE, LockL, LetamendiaA, GorskaAE, GryfeR, GallingerS, MosesHL, AttisanoL. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res, 67:75–84. 2007.
136.
LamaVN, PhanSH. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc, 3:373–376. 2006.
137.
LambethJD. Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy. Free Radic Biol Med, 43:332–347. 2007.
138.
LarueL, BellacosaA. Epithelial–mesenchymal transition in development and cancer: Role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene, 24:7443–7454. 2005.
139.
LeeJM, DedharS, KalluriR, ThompsonEW. The epithelial–mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol, 172:973–981. 2006.
LesterRD, JoM, MontelV, TakimotoS, GoniasSL. uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells. J Cell Biol, 178:425–436. 2007.
142.
LewisCE, De PalmaM, NaldiniL. Tie2-expressing monocytes and tumor angiogenesis: Regulation by hypoxia and angiopoietin-2. Cancer Res, 67:8429–8432. 2007.
143.
LiX, LewisMT, HuangJ, GutierrezC, OsborneCK, WuMF, HilsenbeckSG, PavlickA, ZhangX, ChamnessGC, WongH, RosenJ, ChangJC. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst, 100:672–679. 2008.
144.
LiY, YangJ, DaiC, WuC, LiuY. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest, 112:503–516. 2003.
145.
LimSO, GuJM, KimMS, KimHS, ParkYN, ParkCK, ChoJW, ParkYM, JungG. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology, 135:2128–2140. 2008.
LiuH, NishitohH, IchijoH, KyriakisJM. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol, 20:2198–2208. 2000.
148.
LiuY. Epithelial to mesenchymal transition in renal fibrogenesis: Pathological significance, molecular mechanisms and therapeutic intervention. J Am Soc Nephrol, 15:1–12. 2004.
149.
LiuY. Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol, 287:F7–16. 2004.
150.
LochterA, GalosyS, MuschlerJ, FreedmanN, WerbZ, BissellMJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol, 139:1861–1872. 1997.
151.
LuJ, LanderholmTE, WeiJS, DongXR, WuSP, LiuX, NagataK, InagakiM, MajeskyMW. Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol, 240:404–418. 2001.
152.
MaL, Teruya–FeldsteinJ, WeinbergRA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature, 449:682–688. 2007.
153.
MalumbresM, PellicerA. Ras pathways to cell cycle and cell transformation. Front Biosci, 3:d887–912. 1998.
154.
ManiSA, GuoW, LiaoMJ, EatonEN, AyyananA, ZhouAY, BrooksM, ReinhardF, ZhangCC, ShipitsinM, CampbellLL, PolyakK, BriskenC, YangJ, WeinbergRA. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell, 133:704–715. 2008.
155.
MareelM, LeroyA. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev, 83:337–376. 2003.
156.
MarnettLJ, RigginsJN, WestJD. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J Clin Invest, 111:583–593. 2003.
McCordJM, FridovichI. Superoxide dismutase: An enzymic function for erythrocuprein (hemocuprein)J Biol Chem, 244:6049–6055. 1969.
160.
MenkeA, PhilippiC, VogelmannR, SeidelB, LutzMP, AdlerG, WedlichD. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res, 61:3508–3517. 2001.
161.
MittalCK, MuradF. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3’,5’-monophosphate formation. Proc Natl Acad Sci USA, 74:4360–4364. 1977.
162.
MjaatvedtCH, MarkwaldRR. Induction of an epithelial-mesenchymal transition by an in vivo adheron-like complex. Dev Biol, 136:118–128. 1989.
163.
MontesanoR, SorianoJV, HosseiniG, PepperMS, SchramekH. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin–Darby canine kidney epithelial cells. Cell Growth Differ, 10:317–332. 1999.
MorelAP, LièvreM, ThomasC, HinkalG, AnsieauS, PuisieuxA. Generation of breast cancer stem cells through epithelial–mesenchymal transition. PLoS ONE, 3:e2888. 2008.
166.
MoriK, ShibanumaM, NoseK. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res, 64:7464–7472. 2004.
167.
MorrowJD, AwadJA, KatoT, TakahashiK, BadrKF, Roberts IILJ, BurkRF. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Invest, 92:2502–2507. 1992.
168.
MoustakasA, HeldinC-H. Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci, 98:1512–1520. 2007.
169.
MoustakasA, PardaliK, GaalA, HeldinCH. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett, 82:85–91. 2002.
170.
MurrayNR, DavidsonLA, ChapkinRS, Clay GustafsonW, SchattenbergDG, FieldsAP. Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis. J Cell Biol, 145:699–711. 1999.
171.
NakayaY, ShengG. Epithelial to mesenchymal transition during gastrulation: An embryological view. Develop Growth Differ, 50:755–766. 2008.
172.
NawshadA, LaGambaD, and HayED. Transforming growth factor beta (TGFbeta) signaling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT)Arch Oral Biol, 49:675–689. 2004.
173.
NawshadA, LagambaD, PoladA, HayED. Transforming growth factor-beta signaling during epithelial–mesenchymal transformation: Implications for embryogenesis and tumor metastasis. Cells Tissues Organs, 179:11–23. 2005.
174.
NelsonWJ, NusseR. Convergence of Wnt, β-catenin, and cadherin pathways. Science, 303:1483–1487. 2004.
175.
NgYY, FanJM, MuW, Nikolic–PatersonDJ, YangWC, HuangTP, AtkinsRC, LanHY. Glomerular epithelial–myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant, 14:2860–2872. 1999.
NiessenK, FuY, ChangL, HoodlessPA, McFaddenD, KarsanA. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol, 182:315–325. 2008.
178.
NovakA, HsuSC, Leung–HagesteijnC, RadevaG, PapkoffJ, MontesanoR, RoskelleyC, GrosschedlR, DedharS. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci USA, 95:4374–4379. 1998.
179.
NovoE, ParolaM. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair, 1:5. 2008.
180.
NovoE, CannitoS, ZamaraE, Valfrè di BonzoL, CaligiuriA, CravanzolaC, CompagnoneA, ColombattoS, MarraF, PinzaniM, ParolaM. Proangiogenic cytokines as -dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol, 170:1942–1953. 2007.
181.
NovoE, MarraF, ZamaraE, Valfrè di BonzoL, CaligiuriA, CannitoS, AntonaciC, ColombattoS, PinzaniM, ParolaM. Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut, 55:90–97. 2006.
182.
OkadaH, DanoffTM, KalluriR, NeilsonEG. Early role of Fsp1 in epithelial–mesenchymal transformation. Am J Physiol, 273:F563–574. 1997.
183.
OloumiA, McPheeT, DedharS. Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophys Acta, 1691:1–15. 2004.
184.
OmenettiA, PopovY, JungY, ChoiSS, WitekRP, YangL, BrownKD, SchuppanD, DiehlAM. The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. Gut, 57:1275–1282. 2008.
PaganR, SánchezA, MartinI, LloberaM, FabregatI, VilaróS. Effects of growth and differentiation factors on the epithelial–mesenchymal transition in cultured neonatal rat hepatocytes. J Hepatol, 31:895–904. 1999.
190.
PalaciosF, PriceL, SchweitzerJ, CollardJG, D'Souza–SchoreyC. An essential role for ARF6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J, 20:4973–4986. 2001.
191.
PapaharalambusCA, GriendlingKK. Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med, 17:48–54. 2007.
192.
PapkoffJ, AikawaM. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun, 247:851–858. 1998.
193.
ParkSM, GaurAB, LengyelE, PeterME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev, 22:894–907. 2008.
ParolaM, BellomoG, RobinoG, BarreraG, DianzaniMU. 4-Hydroxynonenal as a biological signal: Molecular bases and pathophysiological implication. Antioxid Redox Signal, 1:255–284. 1999.
196.
ParolaM, MarraF, PinzaniM. Myofibroblast-like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. Mol Asp Med, 29:58–66. 2008.
197.
Pasca di MaglianoM, HebrokM. Hedgehog signaling in cancer formation and maintenance. Nat Rev Cancer, 3:903–911. 2003.
198.
PeinadoH, BallestarE, EstellerM, CanoA. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol, 24:306–319. 2004.
199.
PeinadoH, OlmedaD, CanoA. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?Nat Rev Cancer, 7:415–428. 2007.
PennathurS, HeineckeJW. Oxidative stress and endothelial dysfunction in vascular disease. Curr Diab Rep, 7:257–264. 2007.
204.
PersonAD, KlewerSE, RunyanRB. Cell biology of cardiac cushion development. Int Rev Cytol, 243:287–335. 2005.
205.
PoelmannRE, Gittenberger–de GrootAC, MentinkMM, DelpechB, GirardN, ChristB. The extracellular matrix during neural crest formation and migration in rat embryos. Anat Embryol, 182:29–39. 1990.
206.
PoliG, SchaurRJ. 4-Hydroxynonenal in the phatomechanisms of oxidative stress. IUBMB Life, 50:315–321. 2000.
207.
PolyakK, WeinbergRA. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer, 9:265–273. 2009.
208.
PotentaS, ZeisbergE, KalluriR. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer, 99:1375–1379. 2008.
209.
PrzybyloJA, RadiskyDC. Matrix metalloproteinase-induced epithelial–mesenchymal transition: Tumor progression at Snail's pace. Int J Biochem Cell Biol, 39:1082–1088. 2007.
210.
RadiskyDC, KennyPA, BissellMJ. Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?J Cell Biochem, 101:830–839. 2007.
211.
RadiskyDC, LevyDD, LittlepageLE, LiuH, NelsonCM, FataJE, LeakeD, GoddenEL, AlbertsonDG, NietoMA, WerbZ, BissellMJ. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436:123–127. 2005.
212.
RadomskiMW, PalmerRMJ, MoncadaS. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin, nitric oxide. Br J Pharmacol, 92:639–646. 1987.
213.
RahmanI, BiswasSK, KodeA. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol, 533:222–239. 2006.
214.
RahmanI, YangSR, BiswasSK. Current concepts of redox signaling in the lungs. Antioxid Redox Signal, 8:681–689. 2006.
215.
RankinEB, GiacciaAJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Diff, 15:678–685. 2008.
216.
RastaldiMP, FerrarioF, GiardinoL, Dell'AntonioG, GrilloC, GrilloP, StrutzF, MüllerGA, ColasantiG, D'AmicoG. Epithelial–mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int, 62:137–146. 2002.
217.
RezaeeM, IsokawaK, HalliganN, MarkwaldRR, KrugEL. Identification of an extracellular 130-kDa protein involved in early cardiac morphogenesis. J Biol Chem, 268:4404–4411. 1993.
218.
RhyuDY, YangY, HaH, LeeGT, SongJS, UhST, LeeHB. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol, 16:667–675. 2005.
219.
RobertsonH, KirbyJA, YipWW, JonesDE, BurtAD. Biliary epithelial–mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology, 45:977–981. 2007.
220.
RobsonEJ, KhaledWT, AbellK, WatsonCJ. Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines. Differentiation, 74:254–264. 2006.
221.
RussoFP, AlisonMR, BiggerBW, AmofahE, FlorouA, AminF, Bou–GhariosG, JefferyR, IredaleJP, ForbesSJ. The bone marrow functionally contributes to liver fibrosis. Gastroenterology, 130:1807–1821. 2006.
222.
RygielKA, RobertsonH, MarshallHL, PekalskiM, ZhaoL, BoothTA, JonesDE, BurtAD, KirbyJA. Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest, 88:112–123. 2008.
Santamaria–KisielL, Rintala–DempseyAC, ShawGS. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J, 396:201–214. 2006.
225.
SarrióD, Rodriguez–PinillaSM, HardissonD, CanoA, Moreno–BuenoG, PalaciosJ. Epithelial–mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res, 68:989–997. 2008.
226.
SavagnerP, KusewittDF, CarverEA, MagninoF, ChoiC, GridleyT, HudsonLG. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J Cell Physiol, 202:858–866. 2005.
227.
SavagnerP. Leaving the neighborhood: Molecular mechanisms involved during epithelial–mesenchymal transition. BioEssays, 23:912–923. 2001.
228.
SchmalhoferO, BrabletzS, BrabletzT. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev, 28:151–166. 2009.
229.
SchneiderM, HansenJL, SheikhSP. S100A4: A common mediator of epithelial–mesenchymal transition, fibrosis and regeneration in diseases?J Mol Med, 86:507–522. 2008.
230.
SchreckR, BaeuerlePA. Reactive oxygen intermediates as apparently widely used messengers in the activation of NFκB transcription factor and HIV-1. Trends Cell Biol, 1:39–42. 1991.
231.
SemenzaGL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3:721–732. 2003.
232.
ShirakiharaT, SaitohM, MiyazonoK. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell, 18:3533–3544. 2007.
233.
ShockF, PerrimonN. Molecular mechanisms of epithelial morphogenesis. Annu Rev Cell Dev Biol, 18:463–493. 2002.
234.
SimonMC, KeithB. The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol, 9:285–296. 2008.
SlaterTF. Necrogenic action of carbon tetrachloride in the rat: A speculative mechanism based on activation. Nature, 209:36–40. 1966.
237.
SobermanRJ. The expanding network of redox signaling: new observations, complexities, and perspectives. J Clin Invest, 111:571–574. 2003.
238.
SobradoVR, Moreno–BuenoG, CubilloE, HoltLJ, NietoMA, PortilloF, CanoA. The class I bHLH factors E2-2A and E2-2B regulate EMT. J Cell Sci, 122:1014–1024. 2009.
239.
SomasiriA, HowarthA, GoswamiD, DedharS, RoskelleyCD. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci, 114:1125–1136. 2001.
240.
StrutzF, MüllerGA, NeilsonEG. Transdifferentiation: A new angle on renal fibrosis. Exp Nephrol, 4:267–270. 1996.
241.
StrutzF, OkadaH, LoCW, DanoffT, CaroneRL, TomaszewskiJE, NeilsonEG. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol, 130:393–405. 1995.
242.
StrutzFM. EMT and proteinuria as progression factors. Kidney Int, 75:475–481. 2009.
243.
TakaiY, SasakiT, MatozakiT. Small GTP-binding proteins. Physiol Rev, 81:153–208. 2001.
244.
TarabykinaS, GriffithsTR, TulchinskyE, MellonJK, BronsteinIB, KriajevskaM. Metastasis-associated protein S100A4: Spotlight on its role in cell migration. Curr Cancer Drug Targets, 7:217–228. 2007
245.
TarabykinaS, KriajevskaM, ScottDJ, HillTJ, LafitteD, DerrickPJ, DodsonGG, LukanidinE, BronsteinI. Heterocomplex formation between metastasis-related protein S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid system. FEBS Lett, 475:187–191. 2000.
246.
TarinD, ThompsonEW, NewgreenDF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res, 65:5996–6000. 2005.
247.
TavazoieSF, AlarcónC, OskarssonT, PaduaD, WangQ, BosPD, GeraldWL, MassaguéJ. Endogenous human microRNAs that suppress breast cancer metastasis. Nature, 451:147–152. 2008.
248.
TemkinV, KarinM. From death receptor to reactive oxygen species and c-Jun N-terminal protein kinase: The receptor-interacting protein 1 odyssey. Immunol Rev, 220:8–21. 2007.
249.
ThannickalVJ, FarnburgBL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol, 279:L1005–L1028. 2000.
TimmermanLA, Grego–BessaJ, RayaA, BertránE, Pérez–PomaresJM, DíezJ, ArandaS, PalomoS, McCormickF, Izpisúa–BelmonteJC, de la PompaJL. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev, 18:99–115. 2004.
255.
TonksKN. Redox redux: Revisiting PTPs and the control of cell signaling. Cell, 121:667–670. 2005.
256.
TonksNK. Protein tyrosine phosphatases: From genes, to function, to disease. Mol Cell Biol, 7:833–845. 2006.
257.
TrelstadRL, HayED, RevelJP. Cell contact during early morphogenesis in the chick embryo. Dev Biol, 16:78–106. 1967.
258.
TrelstadRL, RevelJP, HayED. Tight junctions between cells in the early chick embryo as visualized with the electron microscopy. J Cell Biol, 31:C6–C10. 1966.
259.
TuckerGC, DubandJL, DufourS, ThieryJP. Cell-adhesion and substrate-adhesion molecules: Their instructive roles in neural crest cell migration. Development Suppl, 103:81–94. 1988.
260.
TuckerGC, BoyerB, GavrilovicJ, EmonardH, ThieryJP. Role of collagen as an EMT inducer: Collagen-mediated dispersion of NBT-II rat bladder carcinoma cells. Cancer Res, 50:129–137. 1990.
261.
UchidaK. 4-Hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog Lipid Res, 42:318–343. 2003.
262.
Valfrè, di BonzoL, FerreroI, CravanzolaC, MareschiK, RustichelliD, NovoE, SanavioF, CannitoS, ZamaraE, BerteroM, DavitA, FrancicaS, NovelliF, ColombattoS, FagioliF, ParolaM. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: Engraftment and hepatocyte differentiation versus profibrogenic potential. Gut, 57:223–231. 2008.
263.
VallésAM, BeuvinM, BoyerB. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J Biol Chem, 279:44490–44496. 2004.
264.
VaupelP, MayerA. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev, 26:225–239. 2007.
265.
VenkovCD, LinkAJ, JenningsJL, PliethD, InoueT, NagaiK, XuC, DimitrovaYN, RauscherFJ, NeilsonEG. A proximal activator of transcription in epithelial–mesenchymal transition. J Clin Invest, 117:482–491. 2007.
266.
ViebahnC. Epithelio-mesenchymal transformation during formation of the mesoderm in the mammalian embryo. Acta Anat, 154:79–97. 1995.
267.
VongwiwatanaA, TasanarongA, RaynerDC, MelkA, HalloranPF. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: The role of tubular cells in fibrogenesis. Am J Transplant, 5:1367–1374. 2005.
268.
WeissFU, DaubH, UllrichA. Novel mechanisms of RTK signal generation. Curr Opin Genet Dev, 7:80–86. 1997.
269.
WhiteAA, CrawfordKM, PattCS, LadPJ. Activation of soluble guanylate cyclase from rat lung by incubation or by hydrogen peroxide. J Biol Chem, 251:7304–7312. 1976.
270.
WienholdsE, KloostermanWP, MiskaE, Alvarez–SaavedraE, BerezikovE, de BruijnE, HorvitzHR, KauppinenS, PlasterkRH. MicroRNA expression in zebrafish embryonic development. Science, 309:310–311. 2005.
271.
WillisBC, BorokZ. TGFβ-induced EMT: Mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol, 293:L525–534. 2007.
272.
WillisBC, duBoisRM, BorokZ. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc, 3:377–382. 2006.
273.
WillisBC, LieblerJM, Luby–PhelpsK, NicholsonAG, CrandallED, du BoisRM, BorokZ. Induction of epithelial–mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: Potential role in idiopathic pulmonary fibrosis. Am J Pathol, 166:1321–1332. 2005.
WitztumJL, SteinbergD. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans?Trends Cardiovasc Med, 11:93–102. 2001.
276.
WuWS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev, 25:695–705. 2006.
277.
WuY, DengJ, RychahouPG, QiuS, EversBM, ZhouBP. Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell, 15:416–428. 2009.
278.
WuZ, YangL, CaiL, ZhangM, ChengX, YangX, XuJ. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse. Respir Res, 8:1. 2007.
279.
WynnTA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest, 117:524–529. 2007.
280.
XiaJL, DaiC, MichalopoulosGK, LiuY. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol, 168:1500–1512. 2006.
281.
XueC, PliethD, VenkovC, XuC, NeilsonEG. The gatekeeper effect of epithelial–mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res, 63:3386–3394. 2003.
282.
YamadaM, KuwanoK, MaeyamaT, HamadaN, YoshimiM, NakanishiY, KasperM. Dual-immunohistochemistry provides little evidence for epithelial–mesenchymal transition in pulmonary fibrosis. Histochem Cell Biol, 129:453–462. 2008.
283.
YangJ, WeinbergRA. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell, 14:818–829. 2008.
284.
YangJ, DaiC, LiuY. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am J Pathol, 163:621–632. 2003.
285.
YangL, LinC, LiuZ-R. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from β-catenin. Cell, 127:139–155. 2006.
286.
YiR, O'CarrollD, PasolliHA, ZhangZ, DietrichFS, TarakhovskyA, FuchsE. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet, 38:356–362. 2006.
287.
YiR, QinY, MacaraIG, CullenBR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 17:3011–3016. 2003.
288.
YoungIS, WoodsideJV. Antioxidant in health and disease. J Clin Pathol, 54:176–186. 2001.
289.
ZamaraE, NovoE, ParolaM. Oxidative stress and liver fibrosis: From liver injury to the modulation of cell signaling and response. Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights Volume. AliS, MannDA, FriedmanSL. New York: M/s Sc. Pub, 2004; 93–114.
290.
ZavadilJ, CermakL, Soto-NievesN, BöttingerEP. Integration of TGF-beta/Smad and Jagged1/Notch signaling in epithelial-to-mesenchymal transition. EMBO J, 23:1155–65. 2004.
291.
ZavadilJ, NarasimhanM, BlumenbergM, SchneiderRJ. Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs, 185:157–161. 2007.
292.
ZavadilJ, BöttingerEP. TGF-β and epithelial-to-mesenchymal transition. Oncogene, 24:5764–5774. 2005.
293.
ZeisbergEM, PotentaSE, SugimotoH, ZeisbergM, KalluriR. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol, 19:2282–2287. 2008.
294.
ZeisbergEM, PotentaSE, XieL, ZeisbergM, KalluriR. Discovery of endothelial to mesenchymal transition as a source for carcinoma- associated fibroblasts. Cancer Res, 67:10123–10128. 2007.
ZeisbergM, YangC, MartinoM, DuncanMB, RiederF, TanjoreH, KalluriR. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem, 282:23337–23347. 2007.
301.
ZhangA, DongZ, YangT. Prostaglandin D2 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in MDCK cells. Am J Physiol Renal Physiol, 291:F1332–1342. 2006.
302.
ZhangA, JiaZ, GuoX, YangT. Aldosterone induces epithelial–mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol, 293:F723–731. 2007.
303.
ZhangG, KernanKA, CollinsSJ, CaiX, López–GuisaJM, DegenJL, ShvilY, EddyAA. Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals. J Am Soc Nephrol, 18:846–859. 2007.
304.
ZhangKH, TianHY, GaoX, LeiWW, HuY, WangDM, PanXC, YuML, XuGJ, ZhaoFK, SongJG. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition. Cancer Res, 69:5340–5348. 2009.
305.
ZhouBP, DengJ, XiaW, XuJ, LiYM, GunduzM, HungMC. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial–mesenchymal transition. Nat Cell Biol, 6:931–940. 2004.
306.
ZhuX, SuB, WangX, SmithMA, PerryG. Causes of oxidative stress in Alzheimer diseases. Cell Mol Life Sci, 64:2202–2210. 2007.
307.
ZondagGC, EversEE, ten KloosterJP, JanssenL, van der KammenRA, CollardJG. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial–mesenchymal transition. J Cell Biol, 149:775–782. 2000.
